What to Expect at the Premier Proteomics-Dedicated Forum in 2026
As proteomics increasingly becomes an integral step in drug discovery workflows, there’s never been a more important time to adapt your methodologies to achieve optimal throughput and sensitivity.
The 2nd Proteomics Based Drug Discovery Summit is dedicated to delivering cutting-edge insights into data analysis technologies, advanced proteomics instruments and sample processing strategies. From unravelling disease signaling pathways to illuminating druggable pockets on hard-to-drug proteins, don’t miss this chance to harness proteomics to maximize efficiency in drug discovery.
The 2026 program has been built with proteomics decision makers working across a plethora of modalities to equip you with the tools and techniques to transform your discovery pipelines with unique insights.
Unmissable Event Highlights
Maximize Throughput Without Compromising Sensitivity
Achieving proteomics workflows at an unprecedented scale with optimized analysis methodologies, whilst capturing the depth and breadth of the proteome, with Eisai and Light Horse Therapeutics
Illuminate Post-Translational Modifications
Understand disease signatures by capturing the dynamics of PTMs with highly accurate proteomics instruments, with lessons from Blueprint Medicines and Merck
Unlock Holistic Health Insights With Multi-Omics
Implementing Multi-Omics Into Drug Discovery to Contextualize Proteomics Insights & Make Well-Informed Drug Discovery Decisions with RyboDyn & Cellarity
Optimize & Automate Sample Processing
Work effectively with challenging samples and implementing automation to maintain sample integrity and meet the demand for high throughput proteomics, with AstraZeneca and Sanofi
Achieve Gold-Standard Data Analysis Methodologies
Standardize large-scale proteomics analysis and draw impactful biomedical conclusions whilst storage, sharing and visualizing data securely, with Johnson & Johnson, and Northeastern
Explore Immunopeptidomics, Single-Cell & Spatial Proteomics
Achieve nuanced proteomics understanding to suit your drug discovery goals, unlocking unique insights into the proteome with Aethon Therapeutics, DISCO Pharmaceuticals and Immatics
What’s New for 2026?
2 Technical Workshops
- Sample Processing & Automation
- Implement Multi-Omics for Holistic Insights
Senior Speaker Faculty
- 79% of Director-Level Speakers or Above
More Modalities, More Breakthroughs
- ADCs, Bispecifics, Covalent Inhibitors, Small Molecules, TPD
Explore the Full Event Guide
- Hear from 100% brand new speakers
- Explore case studies on mass spectrometry, chemoproteomics, single-cell and spatial proteomics platforms
- Uncover drug discovery applications across bispecifics, covalent small molecules, TPD, and more
- Review real-live examples on balancing throughput, coverage, and sensitivity of proteomic workflows
- Outline strategies for optimizing large-scale proteomics data analysis methodologies
Attending Companies Include
Explore the Agenda
Hear the latest breakthroughs in throughput, coverage and sensitivity of proteomics methodologies, and uncover data-driven presentations and engaging panel discussions on translating large-scale proteomics data into meaningful drug discovery conclusions.
Partner With Us
Position yourself alongside other proteomics, mass spectrometry and data analysis solution providers, demonstrating your capabilities and increasing your brand awareness to a room full of proteomics decision makers.
Join Biopharma Experts
Be part of cutting-edge discussions with fellow proteomics pioneers to transform drug discovery across a range of modalities, whether you’re working on TPD, ADCs, small molecules or beyond.